ACS Clinical Research Program rss

Positron emission tomography with the glucose analog fluorine-18 FDG studies in patients with clinically responding and nonresponding tumors (© 2003 American Society of Clinical Oncology).

Studies address metabolic image-directed oncologic therapy for gastric cancer(Comments Off on Studies address metabolic image-directed oncologic therapy for gastric cancer)

May 1, 2016

Research findings regarding the effect of metabolic response on gastric cancer are summarized, including the new Alliance 021302 trial.

How successful is NST in increasing breast-conserving surgery rates in TNBC patients?

Historically, neoadjuvant systemic therapy (NST) has been mainly used to convert breast cancer from inoperable to operable; however, today NST also is incorporated into the treatment of patients who initially present with operable disease. NST can allow some patients with stage II-III breast cancer who initially present with disease extent necessitating mastectomy to possibly undergo […]

Dissemination and implementation: Translating cancer guidelines and clinical trial outcomes into everyday practice

Dissemination strategies and implementation research programs, which examine how clinical trials data may be incorporated into clinical use, are the focus of this month’s column.

TME specimen

Rectal cancer resection: Laparoscopic or open—which way forward?

The primary outcome of the Z6051 rectal cancer trial is outlined in this month’s column as are new surgical trial concepts that resulted from this study.

Figure 1. SWOG S1316 Schema

Prospective comparative effectiveness trial for malignant bowel obstruction: SWOG S1316

The aim and approach of the Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction trial is the focus of this month’s column.


More in this category

« Older Posts   

Contact

Bulletin of the American College of Surgeons
633 N. Saint Clair St.
Chicago, IL 60611

Archives

Download the Bulletin App


Get it on Google Play